Net Income (Loss) Attributable to Parent in USD of Cabaletta Bio, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cabaletta Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q3 2018 to Q3 2025.
  • Cabaletta Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$44.9M, a 46.5% decline year-over-year.
  • Cabaletta Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$159M, a 52.2% decline year-over-year.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$116M, a 71.2% decline from 2023.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$67.7M, a 27.7% decline from 2022.
  • Cabaletta Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$53M, a 14.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Cabaletta Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$159M -$44.9M -$14.2M -46.5% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$144M -$45.1M -$17.5M -63.5% 01 Apr 2025 30 Jun 2025 10-Q 10 Nov 2025
Q1 2025 -$127M -$35.9M -$10.9M -43.5% 01 Jan 2025 31 Mar 2025 10-Q 10 Nov 2025
Q4 2024 -$116M -$32.6M -$11.7M -56% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$104M -$30.6M -$14.2M -86.2% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 -$90M -$27.6M -$13.1M -90.5% 01 Apr 2024 30 Jun 2024 10-Q 10 Nov 2025
Q1 2024 -$76.9M -$25M -$9.19M -58% 01 Jan 2024 31 Mar 2024 10-Q 10 Nov 2025
Q4 2023 -$67.7M -$20.9M -$5.19M -33.1% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$62.5M -$16.4M -$5.02M -43.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$57.5M -$14.5M -$1.58M -12.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Nov 2024
Q1 2023 -$55.9M -$15.9M -$2.91M -22.5% 01 Jan 2023 31 Mar 2023 10-Q 14 Nov 2024
Q4 2022 -$53M -$15.7M -$1.8M -13% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$51.2M -$11.4M +$133K +1.15% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$51.3M -$12.9M -$1.77M -15.9% 01 Apr 2022 30 Jun 2022 10-Q 09 Nov 2023
Q1 2022 -$49.5M -$12.9M -$3.24M -33.4% 01 Jan 2022 31 Mar 2022 10-Q 09 Nov 2023
Q4 2021 -$46.3M -$13.9M -$4.58M -49.2% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$41.7M -$11.6M -$3.17M -37.7% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$38.5M -$11.1M -$2.99M -36.6% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$35.6M -$9.7M -$2.22M -29.6% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$33.3M -$9.31M -$3.91M -72.3% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$29.4M -$8.39M -$3.74M -80.5% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 -$25.7M -$8.15M -$4.79M -143% 01 Apr 2020 30 Jun 2020 10-Q 01 Nov 2021
Q1 2020 -$20.9M -$7.49M -$3.95M -112% 01 Jan 2020 31 Mar 2020 10-Q 01 Nov 2021
Q4 2019 -$16.9M -$5.4M 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 -$4.65M +$4.63M +49.9% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$3.36M 01 Apr 2019 30 Jun 2019 10-Q 10 Nov 2020
Q1 2019 -$3.53M 01 Jan 2019 31 Mar 2019 10-Q 10 Nov 2020
Q3 2018 -$9.28M 01 Jul 2018 30 Sep 2018 10-Q 05 Dec 2019

Cabaletta Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$116M -$48.2M -71.2% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$67.7M -$14.7M -27.7% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$53M -$6.69M -14.4% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$46.3M -$13M -38.8% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$33.3M -$16.4M -96.8% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$16.9M -$4.74M -38.9% 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$12.2M 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.